Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe survey.
Collinge M, Neff-LaFord H, Akella S, Fogal B, Fraser K, Jabbour J, Harper K, Maier CC, Malherbe L, Marshall N, Rao GK, Raman K, Skaggs H, Weber F, Fuller CL. Collinge M, et al. Among authors: fuller cl. Regul Toxicol Pharmacol. 2024 Apr 18;150:105630. doi: 10.1016/j.yrtph.2024.105630. Online ahead of print. Regul Toxicol Pharmacol. 2024. PMID: 38642729
Patient and Process Outcomes among Pediatric Patients Undergoing Appendectomy during the COVID-19 Pandemic: An International Retrospective Cohort Study.
Matava CT, Tighe NTG, Baertschiger R, Wilder RT, Correll L, Staffa SJ, Zurakowski D, Kato MA, Meier PM, Raman V, Reddy SK, Roque RA, Peterson MB, Zhong J, Edala T, Greer TJ, von Ungern-Sternberg BS, Cravero J, Simpao AF; PEACOC Collaborators. Matava CT, et al. Anesthesiology. 2023 Jul 1;139(1):35-48. doi: 10.1097/ALN.0000000000004570. Anesthesiology. 2023. PMID: 37014980 Free PMC article.
Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics.
Grimaldi C, Ibraghimov A, Kiessling A, Rattel B, Ji C, Fuller CL, Brennan FR, Regenass-Lechner F, Shenton J, Price KD, Piché MS, Steeves MA, Prell R, Dudal S, Kronenberg S, Freebern W, Blanset D. Grimaldi C, et al. Among authors: fuller cl. Drug Discov Today. 2023 Feb;28(2):103440. doi: 10.1016/j.drudis.2022.103440. Epub 2022 Nov 12. Drug Discov Today. 2023. PMID: 36375739 Free article. Review.
Nonclinical Studies that Support Viral Vector-Delivered Gene Therapies: An EFPIA Gene Therapy Working Group Perspective.
Bolt MW, Whiteley LO, Lynch JL, Lauritzen B, Fernández de Henestrosa AR, MacLachlan T, Ulrich P, Philip BK, Mahalingaiah PK, Fuller CL, Compton DR. Bolt MW, et al. Among authors: fuller cl. Mol Ther Methods Clin Dev. 2020 Sep 1;19:89-98. doi: 10.1016/j.omtm.2020.08.017. eCollection 2020 Dec 11. Mol Ther Methods Clin Dev. 2020. PMID: 33024793 Free PMC article.
Comparison of immune system development in nonclinical species and humans: Closing information gaps for immunotoxicity testing and human translatability.
Skaggs H, Chellman GJ, Collinge M, Enright B, Fuller CL, Krayer J, Sivaraman L, Weinbauer GF. Skaggs H, et al. Among authors: fuller cl. Reprod Toxicol. 2019 Oct;89:178-188. doi: 10.1016/j.reprotox.2019.06.005. Epub 2019 Jun 21. Reprod Toxicol. 2019. PMID: 31233776 Free article. Review. No abstract available.
Conditional ablation and recovery of forebrain neurogenesis in the mouse.
Singer BH, Jutkiewicz EM, Fuller CL, Lichtenwalner RJ, Zhang H, Velander AJ, Li X, Gnegy ME, Burant CF, Parent JM. Singer BH, et al. Among authors: fuller cl. J Comp Neurol. 2009 Jun 20;514(6):567-82. doi: 10.1002/cne.22052. J Comp Neurol. 2009. PMID: 19363795 Free PMC article.
38 results